UL research centre, PMTC embarks on new phase in pharma technology

Posted on Mon, 30th September 2019

UL research centre, PMTC embarks on new phase in pharma technology

The Pharmaceutical Manufacturing Technology Centre at University of Limerick's Bernal Institute is embarking on a 'new phase’ after securing €5 million in funding.
The research centre provides advanced technology solutions for the pharma-sector.
PMTC has appointed a new director and will expand its research focus to include data analytics as it launches ‘PMTC Phase 2’ following confirmation of funding from Enterprise Ireland, with support from IDA Ireland.
A key objective for PMTC is to place small and medium enterprises into direct contact with multinational corporations operating in the pharmaceutical and biopharma sectors in Ireland, allowing them to collaborate in an innovative research programme.
PMTC Director Sarah Hayes said there is an appetite for innovation from the broad industry base in Ireland with its globally unique eco-system in the biopharmaceutical sector.
"If you ask peers in pharma multinationals in Europe and the US, the research collaboration in Ireland is looked at with envy," she added.
The centre funds three core research themes: Plant Cleaning, Process Control and Optimisation and Data Analytics and Utilisation.
The centre's industry membership is continuing to grow year on year with the current membership base of 38 companies comprising 60% SMEs and 40% multinationals.

Latest News